Long-term investor

Obesity and Diabetes Drugs @etdiabetesmed

Investor on eToro since 2019-11-18, 679 copiers, risk score 5 of 10, 25% of 65 trades profitable over the last year. Positions are the venue's reported weights; dollar sizes are not published.

Record

  • Tracked since 2019-11-30 (2496 days), 50 trades recorded
  • Returns: week n/a · month +6.3% · 90 days +15.7% · 6 months +11.1% · 1 year +20.3% · all +121.9%
  • Max drawdown -12.6% · Sharpe 0.57 · win rate 73% · data quality High
  • Source: eToro (public profiles) (eToro public profiles; typical delay 1 hours)

Open positions

  • DXCM · 6.5% · long
  • MRK · 5.8% · long
  • ALKS · 5.3% · long
  • LLY · 5.2% · long
  • PFE · 5.0% · long
  • JNJ · 5.0% · long
  • AMGN · 4.9% · long
  • HALO · 4.7% · long
  • ASND · 4.7% · long
  • NBIX · 4.6% · long
  • WST · 4.6% · long
  • VRTX · 4.5% · long

Copy on paper, free More traders How copying works

Past performance does not predict future results. Copy trading can lose money. Meror is software, not an adviser.

Krishan Thushyanthan, carrying on business as Meror
303 Bristol Rd W, Mississauga, Ontario L5R 2H1, Canada · support@meror.ca
Explore traders·Prediction markets·Styles·Data sources·Pricing·FAQ·About·Contact
Terms·Risk disclosure·Privacy·Billing terms·Copy authorization·Cookie settings

Meror is software, not a broker, dealer or adviser, and is not registered with the Ontario Securities Commission, any Canadian securities regulator or the U.S. SEC. Copy trading can lose money, including the whole amount copied. Meror never holds customer funds; past performance does not predict future results. Payments are processed by Stripe.

© 2026 Krishan Thushyanthan, carrying on business as Meror. The rankings, scores and compiled statistics on this site are Meror's own work and may not be scraped, bulk-downloaded or used to build a competing product or dataset. Source records belong to their publishers and are attributed on each source page.